Fresenius Medical Care Acquires Peritoneal Dialysis Business from Gambro - MarketWatch (press release)

Fresenius Medical Care Acquires Peritoneal Dialysis Business from Gambro
MarketWatch (press release)
Gambro has decided to prioritize its investments in the hemodialysis field. Fresenius Medical Care is taking advantage of this opportunity to expand its ...
Fresenius to Add Gambro's PD Unit Zacks.com
Gambro to sell its peritoneal dialysis business to Fresenius NephrOnline
Fresenius Medical (FMS) Announces Acquisition of Gambro's PD Business StreetInsider.com (subscription)
BusinessWeek
all 30 news articles »

continue reading

Fresenius to acquire Gambro peritoneal dialysis unit - Zenopa

Fresenius to acquire Gambro peritoneal dialysis unit
Zenopa
Fresenius has agreed a deal to expand its offering of homecare products via the acquisition of fellow medical company Gambro's worldwide peritoneal dialysis ...

and more »

continue reading

LifeSpan Hires Senior QEH&S Executive - PR.com (press release)

LifeSpan Hires Senior QEH&S Executive
PR.com (press release)
In addition, her tenure spans multiple organizations, including – Gambro BCT, the Colorado Department of Public Health and Environment, the National ...

and more »

continue reading

Healthcare services co. CEO lists 4BD home for $2.55M [more] - Blockshopper


Blockshopper
Healthcare services co. CEO lists 4BD home for $2.55M [more]
Blockshopper
Previously, he worked with Warburg Pincus LLC, was the president and COO of Gambro Healthcare/USA, was the president, CEO and director of SSI, ...

continue reading

ADR REPORT: Shares Close Lower On Concerns About Recovery - Wall Street Journal

ADR REPORT: Shares Close Lower On Concerns About Recovery
Wall Street Journal
XE), a German kidney-dialysis company, announced it has signed an agreement to acquire Gambro's worldwide peritoneal dialysis business. ...

continue reading

MOUNTAIN HIGHLANDS, LLC v. HENDRICKS - Leagle.com

MOUNTAIN HIGHLANDS, LLC v. HENDRICKS
Leagle.com
Gambro, Inc., 428 F.3d 933, 935 (10th Cir. 2005). On those issues for which it bears the burden of proof at trial, the nonmovant "must go beyond the ...

continue reading

FMC übernimmt Peritonealdialyse-Geschäft von Gambro - Märkische Allgemeine


DerBörsianer.com

continue reading

Common Blood Cell Variations Not An Independent Predictor Of Adverse Outcomes ... - Medical News Today (press release)

Common Blood Cell Variations Not An Independent Predictor Of Adverse Outcomes ...
Medical News Today (press release)
Peter Stenvinkel is a member of the Scientific Advisory Board Gambro and has given lectures at meetings organized by Amgen, Baxter, Genzyme, Roche and Astra ...

and more »

continue reading